Publisher: Icon Group International, Inc.
Category: Diseases & Conditions

Diseases & Conditions market research reports by Icon Group International, Inc.

(630 reports matching your criteria)
    • The 2025-2030 World Outlook for Interleukin Blockers for Psoriasis Treatments

      The 2025-2030 World Outlook for Interleukin Blockers for Psoriasis Treatments This study covers the world outlook for interleukin blockers for psoriasis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More

    • The 2025-2030 World Outlook for Cancer Gene Therapies

      The 2025-2030 World Outlook for Cancer Gene Therapies This study covers the world outlook for cancer gene therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Leukemia Therapeutics

      The 2025-2030 World Outlook for Leukemia Therapeutics This study covers the world outlook for leukemia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Epilepsy Therapeutics

      The 2025-2030 World Outlook for Epilepsy Therapeutics This study covers the world outlook for epilepsy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Cancer Tumor Profiling

      The 2025-2030 World Outlook for Cancer Tumor Profiling This study covers the world outlook for cancer tumor profiling across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Subcutaneous Immunoglobulins

      The 2025-2030 World Outlook for Subcutaneous Immunoglobulins This study covers the world outlook for subcutaneous immunoglobulins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

    • The 2025-2030 World Outlook for Hemophilia a Gene Therapies

      The 2025-2030 World Outlook for Hemophilia a Gene Therapies This study covers the world outlook for hemophilia a gene therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More

    • The 2025-2030 World Outlook for Hemophilia a Treatments

      The 2025-2030 World Outlook for Hemophilia a Treatments This study covers the world outlook for hemophilia a treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2025-2030 World Outlook for Hemophilia Drugs

      The 2025-2030 World Outlook for Hemophilia Drugs This study covers the world outlook for hemophilia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More

    • The 2025-2030 World Outlook for Sphygmomanometers

      The 2025-2030 World Outlook for Sphygmomanometers This study covers the world outlook for sphygmomanometers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More

    • The 2025-2030 World Outlook for Cutaneous Melanoma Therapeutics

      The 2025-2030 World Outlook for Cutaneous Melanoma Therapeutics This study covers the world outlook for cutaneous melanoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Hematological Disorder Drugs and Diagnostics

      The 2025-2030 World Outlook for Hematological Disorder Drugs and Diagnostics This study covers the world outlook for hematological disorder drugs and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.) ... Read More

    • The 2025-2030 World Outlook for Herpes Marker Testing

      The 2025-2030 World Outlook for Herpes Marker Testing This study covers the world outlook for herpes marker testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Herpes Simplex Virus Infections

      The 2025-2030 World Outlook for Herpes Simplex Virus Infections This study covers the world outlook for herpes simplex virus infections across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy

      The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy This study covers the world outlook for HER-2 positive breast cancer chemotherapy across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More

    • The 2025-2030 World Outlook for Basal Cell Carcinoma Treatments

      The 2025-2030 World Outlook for Basal Cell Carcinoma Treatments This study covers the world outlook for basal cell carcinoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Bariatric (Obesity) Surgical Devices

      The 2025-2030 World Outlook for Bariatric (Obesity) Surgical Devices This study covers the world outlook for bariatric (obesity) surgical devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More

    • The 2025-2030 World Outlook for Clinical Vital Signs Monitoring Devices

      The 2025-2030 World Outlook for Clinical Vital Signs Monitoring Devices This study covers the world outlook for clinical vital signs monitoring devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More

    • The 2025-2030 World Outlook for Non-Hematological Cancer Treatments

      The 2025-2030 World Outlook for Non-Hematological Cancer Treatments This study covers the world outlook for non-hematological cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More

    • The 2025-2030 World Outlook for Non-Hodgkin Lymphoma

      The 2025-2030 World Outlook for Non-Hodgkin Lymphoma This study covers the world outlook for non-Hodgkin lymphoma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

    • The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Treatments

      The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Treatments This study covers the world outlook for non-Hodgkin lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Diabetes Injection Pens

      The 2025-2030 World Outlook for Diabetes Injection Pens This study covers the world outlook for diabetes injection pens across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2025-2030 World Outlook for Diabetes Therapeutics

      The 2025-2030 World Outlook for Diabetes Therapeutics This study covers the world outlook for diabetes therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Diabetic Footwear

      The 2025-2030 World Outlook for Diabetic Footwear This study covers the world outlook for diabetic footwear across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More

    • The 2025-2030 World Outlook for Diabetic Gastroparesis Drugs

      The 2025-2030 World Outlook for Diabetic Gastroparesis Drugs This study covers the world outlook for diabetic gastroparesis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

4 5 6 7 8 9 10 11 12 13

Cookie Settings